DiscoveryProbe™ NF-κB Signaling Compound Library Plus
Catalog No.
L1044P
A unique collection of 178 NF-κB inhibitors for NF-κB signaling pathway research.
Featured Products
| Catalog No. | Product Name | Summary | Targets | CAS Number | Smiles |
| A4084 | Vorinostat (SAHA, MK0683) | HDAC inhibitor | HDAC | 149647-78-9 | C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO |
| A4090 | JNJ-26481585 | Potent HDAC inhibitor | HDAC | 875320-29-9 | CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO |
| A4093 | ITF2357 (Givinostat) | HDAC inhibitor | HDAC | 732302-99-7 | CCN(CC)CC1=CC2=C(C=C(COC(NC3=CC=C(C(NO)=O)C=C3)=O)C=C2)C=C1.O.Cl |
| A4101 | Tubastatin A | HDAC6 inhibitor,potent and selective | HDAC | 1252003-15-8 | CN(C1)CCC2=C1C3=C(N2CC4=CC=C(C(NO)=O)C=C4)C=CC=C3 |
| A4104 | AR-42 (OSU-HDAC42) | HDAC inhibitor,novel and potent | HDAC | 935881-37-1 | CC(C)C(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO |
| B1585 | SC-514 | ATP-competitive IKK-2 inhibitor, orally active | IκB/IKK | 354812-17-2 | C1=CSC=C1C2=CC(=C(S2)C(=O)N)N |
| B2069 | ZLN005 | transcriptional regulator of PGC-1α | PGC-1α | 49671-76-3 | CC(C)(C)C1=CC=C(C=C1)C2=NC3=CC=CC=C3N2 |
| B4880 | WS6 | inducer of β cell proliferation | IκB/IKK | 1421227-53-3 | CN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)CC3=CC=C(C=C3)OC4=NC=NC(=C4)NC(=O)C5CC5)C(F)(F)F |
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
| Form | Pre-dissolved DMSO solutions | Stability | Solution: -20°C for 12 months, -80°C for 24 months |
| Packaging | 96-well rack with Matrix 2D Barcoded ScrewTop Storage tubes (250 μL or 100 μL/well, 10 mM DMSO). 96-well DeepWell format with peelable foil seal and EVA cap (100 μL/well, 10 mM DMSO). |
||
| Shipping Condition | Evaluation sample solution: ship with blue ice All other available size: ship with RT, or blue ice upon request |
||
-- Available in stock with overnight delivery and free shipping over $500.
-- Cost-effective and competitive price to save your budget.
-- Potent, selective and cell-permeable in inhibiting or activating target molecules.
-- Diverse in chemical structure and route of administration (oral/i.m/i.v injection etc.)
-- Detailed files describing potency, selectivity and applications etc.
-- Supported by published data from top peer-reviewed journals.
-- Guaranteed high quality with NMR and HPLC validation.